Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TolaSure Phase 1 in Healthy Volunteers
NCT03620175Phase 1Completed
- Sponsor
- BioMendics
- Start
- Jul 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of TolaSure Vehicle Gel in wound healing, sponsored by BioMendics. Primary endpoints: Blood and Urine Chemistries at Day 14 and Cutaneous Tolerability at Day 14. Started Jul 2018; status: completed.
02
Drugs
TolaSure Vehicle Gel
03
Conditions
wound healing
Beyond the preview
Go deeper on NCT03620175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03620175.